Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
$2.09B |
| 2 |
Mastercard
MA
|
$2.06B |
| 3 |
UnitedHealth
UNH
|
$1.3B |
| 4 |
Coca-Cola
KO
|
$1.17B |
| 5 |
Marsh & McLennan
MMC
|
$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.55B |
| 2 |
Apple
AAPL
|
$1.51B |
| 3 |
JPMorgan Chase
JPM
|
$1.34B |
| 4 |
General Dynamics
GD
|
$1.25B |
| 5 |
Wells Fargo
WFC
|
$1.17B |
Sector Composition
| 1 | Technology | 21.49% |
| 2 | Healthcare | 18.42% |
| 3 | Financials | 15.97% |
| 4 | Consumer Discretionary | 9.49% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
AT&T
T
$208B
| $321M | 0.06% |
11,363,940
+8,841,126
| +350% | +$250M |
|
252
Cytokinetics
CYTK
$5.6B
| $321M | 0.06% |
7,988,740
+100,043
| +1% | +$4.02M |
|
253
CyberArk
CYBR
$22.7B
| $315M | 0.06% |
933,316
-216,962
| -19% | -$73.3M |
|
254
HDFC Bank
HDB
$179B
| $315M | 0.06% |
4,744,000
-172,115
| -4% | -$11.4M |
|
255
Guidewire Software
GWRE
$18.1B
| $313M | 0.06% |
1,672,767
+24,991
| +2% | +$4.68M |
|
256
Performance Food Group
PFGC
$16.2B
| $312M | 0.06% |
3,966,667
+57,032
| +1% | +$4.48M |
|
257
Diamondback Energy
FANG
$42.9B
| $312M | 0.06% |
1,950,160
+417,879
| +27% | +$66.8M |
|
258
UDR
UDR
$13B
| $312M | 0.06% |
6,896,625
-29,520
| -0.4% | -$1.33M |
|
259
RTX Corp
RTX
$210B
| $310M | 0.06% |
2,342,935
-286,713
| -11% | -$38M |
|
260
Amcor
AMCR
$19.6B
| $298M | 0.06% |
30,707,205
+2,735,320
| +10% | +$26.5M |
|
261
Blackrock
BLK
$171B
| $298M | 0.06% |
314,397
-28,219
| -8% | -$26.7M |
|
262
Quest Diagnostics
DGX
$20.2B
| $297M | 0.06% |
1,758,265
-25,903
| -1% | -$4.38M |
|
263
Applovin
APP
$158B
| $295M | 0.06% |
1,115,025
-198,362
| -15% | -$52.6M |
|
264
CACI
CACI
$10.4B
| $291M | 0.06% |
793,566
+757,963
| +2,129% | +$278M |
|
265
Independence Realty Trust
IRT
$4.17B
| $288M | 0.06% |
13,570,175
+171,228
| +1% | +$3.64M |
|
266
McKesson
MCK
$85.6B
| $288M | 0.06% |
427,703
+418,524
| +4,560% | +$282M |
|
267
Avidity Biosciences
RNA
$5.98B
| $286M | 0.06% |
9,684,556
+1,578,459
| +19% | +$46.6M |
|
268
CareTrust REIT
CTRE
$7.65B
| $284M | 0.05% |
9,932,283
-1,011,608
| -9% | -$28.9M |
|
269
Southern Company
SO
$101B
| $279M | 0.05% |
3,039,033
+54,824
| +2% | +$5.04M |
|
270
Essential Properties Realty Trust
EPRT
$6.15B
| $278M | 0.05% |
8,511,088
+48,904
| +0.6% | +$1.6M |
|
271
Camden Property Trust
CPT
$11.8B
| $278M | 0.05% |
2,271,077
+192,133
| +9% | +$23.5M |
|
272
PTC Therapeutics
PTCT
$3.99B
| $276M | 0.05% |
5,419,172
+632,049
| +13% | +$32.2M |
|
273
Monster Beverage
MNST
$60.7B
| $275M | 0.05% |
4,693,439
-23,164
| -0.5% | -$1.36M |
|
274
Rush Enterprises Class A
RUSHA
$4.4B
| $273M | 0.05% |
5,117,578
-292,038
| -5% | -$15.6M |
|
|
BPMC
275
DELISTED
Blueprint Medicines
BPMC
| $272M | 0.05% |
3,073,306
-1,208,058
| -28% | -$107M |
|